Project Number 5R01AG061100-04 Agency/Funding Organization NIA Funding Year 2021 View Full Project Details for A Randomized Controlled Trial of Electroconvulsive Therapy plus Usual Care versus Simulated-ECT plus Usual Care for the Acute Management of Severe Agitation in Alzheimer's Dementia (ECT-AD) Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 10. Clinical Therapy Development for the Neuropsychiatric Symptoms of Dementia b. Non-Pharmacological Researcher and Organization Principal Investigator FORESTER, BRENT PETER Principal Investigator First Name BRENT PETER Principal Investigator Last Name FORESTER Awardee Organization McLean Hospital Awardee State Massachusetts Contact PI Country United States Project Detail Funding Opportunity Announcement PAR-18-175: Pilot Clinical Trials for the Spectrum of Alzheimers Disease and Age-related Cognitive Decline (R01 Clinical Trial Optional) FY Overall Cost $2,324,251 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official MCLINDEN, KRISTINA
